Wealthcare Advisory Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$893K Sell
8,632
-1,146
-12% -$102K 0.02% 544
2026
Q1
$702K Sell
9,778
-208
-2% -$16K 0.01% 604
2025
Q4
$792K Sell
9,986
-385
-4% -$30.4K 0.02% 573
2025
Q3
$782K Buy
10,371
+489
+5% +$33.5K 0.02% 568
2025
Q2
$682K Sell
9,882
-102
-1% -$6.69K 0.02% 568
2025
Q1
$676K Sell
9,984
-36
-0.4% -$2.15K 0.02% 518
2024
Q4
$450K Sell
10,020
-605
-6% -$33.9K 0.01% 598
2024
Q3
$668K Sell
10,625
-670
-6% -$39.1K 0.02% 504
2024
Q2
$667K Sell
11,295
-759
-6% -$47.5K 0.02% 475
2024
Q1
$961K Sell
12,054
-282
-2% -$21.5K 0.03% 379
2023
Q4
$974K Buy
12,336
+45
+0.4% +$3.2K 0.04% 318
2023
Q3
$858K Sell
12,291
-782
-6% -$55.4K 0.04% 308
2023
Q2
$904K Sell
13,073
-101
-0.8% -$7.19K 0.04% 310
2023
Q1
$979K Buy
13,174
+460
+4% +$38.6K 0.04% 293
2022
Q4
$1.18M Buy
12,714
+5,170
+69% +$499K 0.06% 249
2022
Q3
$719K Buy
7,544
+307
+4% +$30.4K 0.04% 283
2022
Q2
$671K Sell
7,237
-37
-0.5% -$3.61K 0.04% 266
2022
Q1
$736K Sell
7,274
-1,001
-12% -$105K 0.04% 244
2021
Q4
$854K Buy
8,275
+829
+11% +$76.6K 0.05% 222
2021
Q3
$632K Buy
7,446
+250
+3% +$20.9K 0.04% 276
2021
Q2
$600K Sell
7,196
-72
-1% -$5.9K 0.04% 282
2021
Q1
$547K Buy
7,268
+2,019
+38% +$147K 0.04% 272
2020
Q4
$359K Buy
5,249
+141
+3% +$9.17K 0.03% 294
2020
Q3
$298K Buy
5,108
+33
+0.7% +$2.05K 0.03% 273
2020
Q2
$330K Buy
5,075
+1,360
+37% +$85.6K 0.04% 226
2020
Q1
$220K Buy
3,715
+174
+5% +$11.6K 0.03% 250
2019
Q4
$263K Buy
3,541
+317
+10% +$22.3K 0.03% 257
2019
Q3
$203K Sell
3,224
-66
-2% -$3.91K 0.03% 272
2019
Q2
$179K Buy
3,290
+390
+13% +$21K 0.03% 286
2019
Q1
$156K Buy
2,900
+1,059
+58% +$65.4K 0.03% 271
2018
Q4
$121K Buy
1,841
+158
+9% +$11.8K 0.02% 277
2018
Q3
$132K Sell
1,683
-1,007
-37% -$72K 0.02% 286
2018
Q2
$173K Buy
2,690
+1,382
+106% +$91.1K 0.03% 235
2018
Q1
$81K Sell
1,308
-55
-4% -$3.95K 0.02% 316
2017
Q4
$99K Buy
1,363
+72
+6% +$5.24K 0.03% 255
2017
Q3
$105K Buy
1,291
+991
+330% +$78.4K 0.03% 205
2017
Q2
$24K Hold
300
0.01% 61
2017
Q1
$24K Hold
300
0.01% 57
2016
Q4
$24K Buy
+300
New +$24.3K 0.01% 61

Other funds holding CVS

Wealthcare Advisory Partners's CVS Position: Q2 2026 in Review

Wealthcare Advisory Partners reduced its CVS Health (CVS) stake by 12% in Q2 2026, selling an estimated $102K and leaving 8,632 shares worth $893K. The position accounts for 0.02% of the portfolio, ranked #544.

Wealthcare Advisory Partners first reported a position in CVS in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.18M in Q4 2022. 504 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Wealthcare Advisory Partners held 8,632 shares of CVS Health worth $893K as of Q2 2026.
  • Wealthcare Advisory Partners sold 1,146 CVS Health shares in Q2 2026, an estimated $102K.
  • CVS Health made up 0.02% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #544 holding.
  • Wealthcare Advisory Partners first reported a position in CVS Health in Q4 2016 and has held it in 39 quarters since.
  • Wealthcare Advisory Partners's CVS Health position peaked at $1.18M in Q4 2022.
  • 504 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.